TLR6 and metabolic dysfunction-associated steatotic liver disease: Besides the classical proinflammatory pathway, TLR6 represents an interesting target identified in our experiments, which has been suggested to play a role in non-alcoholic fatty liver disease and hepatic inflammation [62].